Go to the stock screener
Medical (Diagnostics & Research) stocks
WuXi AppTec has the highest MEQIRI Score in Medical (Diagnostics & Research) today at 84. 10 of 37 companies are Strong.
All 37 Medical (Diagnostics & Research) stocks at MEQIRI, largest first.
As of 12 Nov 2026. How the score is calculated
Companies
37
With score
37
Average score
59
Median P/E
34.7
Median dividend
0.0%
| No. | Stock | Score | Crash risk | P/E | Dividend | Market cap |
|---|---|---|---|---|---|---|
| 1 | Thermo Fisher ScientificTMO | 69 | low | 37.6 | 0.3% | $265.92B |
| 2 | DanaherDHR | 66 | low | 38.4 | 0.7% | $165.55B |
| 3 | WuXi AppTec603259.SS | 84 | 16.6 | 1.4% | $67.65B | |
| 4 | IDEXX LaboratoriesIDXX | 79 | low | 47.0 | 0.0% | $55.35B |
| 5 | Agilent TechnologiesA | 77 | low | 34.8 | 0.6% | $49.89B |
| 6 | NateraNTRA | 43 | high | Loss | 0.0% | $46.38B |
| 7 | WatersWAT | 56 | low | 473.0*forward 28.9 | 0.0% | $46.24B |
| 8 | IQVIA HoldingsIQV | 67 | medium | 32.9 | 0.0% | $45.24B |
| 9 | Mettler-Toledo InternationalMTD | 76 | low | 37.5 | 0.0% | $35.04B |
| 10 | IlluminaILMN | 70 | high | 36.6 | 0.0% | $32.2B |
| 11 | Labcorp HoldingsLH | 64 | low | 30.3 | 0.8% | $30.23B |
| 12 | Quest DiagnosticsDGX | 69 | low | 25.7 | 1.3% | $28.55B |
| 13 | Guardant HealthGH | 45 | Loss | 0.0% | $20.94B | |
| 14 | Medpace HoldingsMEDP | 83 | medium | 36.4 | 0.0% | $18.59B |
| 15 | RevvityRVTY | 56 | low | 69.3 | 0.2% | $17.66B |
| 16 | Eurofins ScientificERF.PA | 61 | low | 30.5 | 0.8% | $17B |
| 17 | Charles River Laboratories InternationalCRL | 55 | medium | 414.3 | 0.0% | $16.42B |
| 18 | ICON PublicICLR | 62 | medium | 34.5 | 0.0% | $14.96B |
| 19 | bioMérieuxBIM.PA | 70 | low | 23.6 | 1.1% | $12.07B |
| 20 | WuXi XDC Cayman2268.HK | 73 | 54.4 | 0.0% | $11.62B | |
| 21 | QiagenQGEN | 76 | low | 27.2 | 5.3% | $10.39B |
| 22 | RadNetRDNT | 44 | medium | Loss | 0.0% | $6.14B |
| 23 | GRAILGRAL | 43 | Loss | 0.0% | $5.65B | |
| 24 | BillionToOneBLLN | 64 | 123.8 | 0.0% | $5.27B | |
| 25 | DiaSorinDIA.MI | 67 | low | 29.9 | 1.6% | $5.14B |
| 26 | Sotera HealthSHC | 55 | medium | 27.4 | 0.0% | $4.69B |
| 27 | CareDxCDNA | 59 | high | 34.7*adjusted 53.1 | 0.0% | $4.26B |
| 28 | Vimian GroupVIMIAN.ST | 58 | low | 51.8 | 0.0% | $2.23B |
| 29 | NeoGenomicsNEO | 40 | high | Loss | 0.0% | $2.19B |
| 30 | VeracyteVCYT | 53 | high | 16.4 | 0.0% | $2.03B |
| 31 | PersonalisPSNL | 41 | Loss | 0.0% | $1.73B | |
| 32 | GeneDx HoldingsWGS | 37 | high | Loss | 0.0% | $1.64B |
| 33 | OPKO HealthOPK | 37 | Loss | 0.0% | $1.27B | |
| 34 | Castle BiosciencesCSTL | 43 | high | Loss | 0.0% | $1.05B |
| 35 | Fulgent GeneticsFLGT | 36 | Loss | 0.0% | $718.03M | |
| 36 | Myriad GeneticsMYGN | 40 | Loss | 0.0% | $548.67M | |
| 37 | VoxelVOX.WA | 82 | low | 13.6 | 1.7% | $400.7M |
* P/E with one-off items or after a one-time drop in earnings. Below it is the adjusted or the forward P/E. The P/E then does not count in the score.